Shackleford attends celebratory signings for public health legislation
Today, State Rep. Shackleford (D-Indianapolis) joined Gov. Braun at the Statehouse for ceremonial bill signings of several impactful health care measures passed during the 2025 legislative session.
The legislation signed includes:
House Enrolled Act 1065: Allows a Cancer Clinical Trial Participation Program to provide payment to Indiana residents for supportive costs, including travel, child care, lodging, parking and tolls, incurred while participating in cancer clinical trials. Participants must meet financial eligibility and residency requirements.
House Enrolled Act 1666: Increases oversight and transparency in the ownership of health care providers.
House Enrolled Act 1604: Helps Hoosiers better manage health care costs by improving out-of-pocket expense credits and allowing cost-sharing payments to be applied to deductibles and maximum out-of-pocket expenses.
Senate Enrolled Act 140: Enhances regulation of pharmacy benefit managers to ensure fairer prescription pricing for patients.
Shackleford, a longtime advocate for equitable and accessible health care, issued the following statement:
“These bills mark crucial progress toward making health care more affordable, transparent and equitable for Hoosiers. From protecting patients against predatory practices to improving accountability in our health care system, each measure signed today moves Indiana in the right direction.
“I’m especially proud to have authored HEA 1065, which creates a fund to help offset the cost of participating in cancer clinical trials. Too often, financial barriers prevent patients from accessing the innovative care they need. This new program will help ensure that more Hoosiers, regardless of income, can benefit from advanced treatments.
“I’m honored to stand alongside fellow lawmakers and advocates in the fight for health equity and look forward to continuing this work to build a stronger, more inclusive system for all.”